LU72320A1 - - Google Patents
Info
- Publication number
- LU72320A1 LU72320A1 LU72320A LU72320A LU72320A1 LU 72320 A1 LU72320 A1 LU 72320A1 LU 72320 A LU72320 A LU 72320A LU 72320 A LU72320 A LU 72320A LU 72320 A1 LU72320 A1 LU 72320A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US462213A US3927197A (en) | 1974-04-19 | 1974-04-19 | Tertiary alcohol stabilized E-series prostaglandins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU72320A1 true LU72320A1 (en:Method) | 1976-03-17 |
Family
ID=23835600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU72320A LU72320A1 (en:Method) | 1974-04-19 | 1975-04-18 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US3927197A (en:Method) |
| JP (1) | JPS5337408B2 (en:Method) |
| AR (1) | AR213271A1 (en:Method) |
| AT (1) | AT348130B (en:Method) |
| AU (1) | AU470631B2 (en:Method) |
| BE (1) | BE828065A (en:Method) |
| BG (1) | BG35326A3 (en:Method) |
| CA (1) | CA1034044A (en:Method) |
| CS (1) | CS191244B2 (en:Method) |
| DD (1) | DD119131A5 (en:Method) |
| DE (1) | DE2516105C3 (en:Method) |
| DK (1) | DK138161B (en:Method) |
| ES (1) | ES436613A1 (en:Method) |
| FI (1) | FI62220C (en:Method) |
| FR (1) | FR2267760B1 (en:Method) |
| GB (1) | GB1474852A (en:Method) |
| HU (1) | HU175405B (en:Method) |
| IE (1) | IE40829B1 (en:Method) |
| IL (1) | IL46994A (en:Method) |
| LU (1) | LU72320A1 (en:Method) |
| NL (1) | NL158384B (en:Method) |
| PH (1) | PH11697A (en:Method) |
| SE (1) | SE428528B (en:Method) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4197257A (en) * | 1976-02-04 | 1980-04-08 | The Upjohn Company | 6-Keto prostaglandin derivatives |
| US4169895A (en) * | 1976-09-28 | 1979-10-02 | Pfizer Inc. | Antisecretory 16,16-dimethyl-17-oxaprostaglandins |
| US4098805A (en) * | 1977-04-11 | 1978-07-04 | The Upjohn Company | 9-deoxy-9-methylene-pgf-type amides |
| ZA831186B (en) * | 1982-03-22 | 1983-11-30 | Upjohn Ltd | Gelled pge2/triacetin solutions |
| ZA837627B (en) * | 1982-10-15 | 1984-06-27 | Procter & Gamble | Storage stable topical pharmaceutical composition containing low dielectric solvents |
| US5409911A (en) * | 1992-09-11 | 1995-04-25 | Merck & Co., Inc. | Prostaglandin analog for treating osteoporosis |
| DE69421936T2 (de) * | 1993-10-27 | 2000-06-29 | Upjohn Co | Stabilisiertes prostaglandin e1 |
| HN1996000101A (es) | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
| US6121253A (en) * | 1998-11-20 | 2000-09-19 | Merck Frosst Canada & Co. | Prostaglandin conjugates for treating or preventing bone disease |
| US20050203086A1 (en) * | 2004-03-04 | 2005-09-15 | Pfizer Inc. | Methods of treatment using an EP2 selective receptor agonist |
| WO2008134828A2 (en) | 2007-05-04 | 2008-11-13 | Katholieke Universiteit Leuven | Tissue degeneration protection |
| US9005183B2 (en) * | 2007-05-16 | 2015-04-14 | Health Knight, Llc | System and method for treating erectile dysfunction |
| AT515356B1 (de) * | 2014-01-30 | 2015-11-15 | Gebro Holding Gmbh | Stabile alkoholische Lösung von Alprostadil |
| JP7354123B2 (ja) | 2018-02-21 | 2023-10-02 | エイアイ・セラピューティクス・インコーポレーテッド | アピリモドとグルタミン酸作動薬を用いた併用療法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3644638A (en) * | 1970-08-24 | 1972-02-22 | American Home Prod | Compositions and methods for relieving bronchial spasm with prostanoic acids and esters |
| US3749800A (en) * | 1971-11-01 | 1973-07-31 | Upjohn Co | Stable composition for dispensing pge2 |
| US3833725A (en) * | 1972-12-08 | 1974-09-03 | Syntex Corp | Dialkylated glycol compositions and medicament preparations containing same |
-
1974
- 1974-04-19 US US462213A patent/US3927197A/en not_active Expired - Lifetime
-
1975
- 1975-03-14 IE IE564/75A patent/IE40829B1/xx unknown
- 1975-04-01 SE SE7503723A patent/SE428528B/xx unknown
- 1975-04-01 IL IL46994A patent/IL46994A/xx unknown
- 1975-04-03 GB GB1375075A patent/GB1474852A/en not_active Expired
- 1975-04-07 AU AU79877/75A patent/AU470631B2/en not_active Expired
- 1975-04-07 PH PH17025A patent/PH11697A/en unknown
- 1975-04-10 NL NL7504274.A patent/NL158384B/xx not_active IP Right Cessation
- 1975-04-11 AT AT278875A patent/AT348130B/de not_active IP Right Cessation
- 1975-04-12 DE DE2516105A patent/DE2516105C3/de not_active Expired
- 1975-04-15 FI FI751108A patent/FI62220C/fi not_active IP Right Cessation
- 1975-04-15 ES ES436613A patent/ES436613A1/es not_active Expired
- 1975-04-17 BG BG029696A patent/BG35326A3/xx unknown
- 1975-04-17 BE BE1006596A patent/BE828065A/xx not_active IP Right Cessation
- 1975-04-17 CS CS752679A patent/CS191244B2/cs unknown
- 1975-04-18 JP JP4736775A patent/JPS5337408B2/ja not_active Expired
- 1975-04-18 DD DD185553A patent/DD119131A5/xx unknown
- 1975-04-18 DK DK167075AA patent/DK138161B/da not_active IP Right Cessation
- 1975-04-18 CA CA224,982A patent/CA1034044A/en not_active Expired
- 1975-04-18 FR FR7512160A patent/FR2267760B1/fr not_active Expired
- 1975-04-18 AR AR258417A patent/AR213271A1/es active
- 1975-04-18 HU HU75PI465A patent/HU175405B/hu unknown
- 1975-04-18 LU LU72320A patent/LU72320A1/xx unknown